Search engine for other government resources

Azacitidine - National Cancer Institute

Azacitidine is approved to treat: Acute myeloid leukemia in adults who had a first complete remission after intensive induction therapy and who are ...
www.cancer.gov/about-cancer/treatment/drugs/azacitidine

Azacitidine C8H12N4O5 - PubChem

Azacitidine is a cytosine analogue and antineoplastic agent used in the therapy of myelodysplastic syndromes. Azacitidine is associated with a low ...
pubchem.ncbi.nlm.nih.gov/compound/Azacitidine

Azacitidine Injection MedlinePlus Drug Information

Azacitidine comes as a powder to be mixed with water and injected subcutaneously (under the skin) or intravenously (into a vein) by a doctor or nurse ...
medlineplus.gov/druginfo/meds/a607068.html

Azacitidine MedlinePlus Drug Information

Azacitidine comes as a tablet to take by mouth. It is usually taken with or without food once daily for the first 14 days of a 28-day cycle. Your ...
medlineplus.gov/druginfo/meds/a620060.html

Azacitidine a review of its use in the management of ...

Azacitidine (Vidaza) is a pyrimidine nucleoside analogue of cytidine. This article reviews the clinical efficacy and tolerability of azacitidine in ...
pubmed.ncbi.nlm.nih.gov/22571445/

DailyMed - VIDAZA- azacitidine injection powder ...

VIDAZA (azacitidine for injection) contains azacitidine, which is a pyrimidine nucleoside analog of cytidine. Azacitidine is ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3495a71a-cc04-4776-851f-f185956f32af

5-AzacytidineAzacitidine

5-Azacytidine is a pyrimidine nucleoside analog that has been discovered more than 40 years ago. Despite remarkable responses in the treatment of ...
pubmed.ncbi.nlm.nih.gov/20072837/

Azacitidine in adult patients with acute myeloid leukemia

Azacitidine is recommended front-line treatment for older patients with acute myeloid leukemia (AML) who are not candidates for intensive treatment ...
pubmed.ncbi.nlm.nih.gov/28693797/

Azacitidine for the treatment of relapsed and refractory ...

The prognosis of patients older than 50 with relapsed or refractory AML is dismal. Azacitidine has been investigated in older AML patients. Here we ...
pubmed.ncbi.nlm.nih.gov/25524177/

DailyMed - Search Results for azacitidine

AZACITIDINE AZACITIDINE (azacitidine) injection, powder, lyophilized, for solution NDC Code(s): 43598-678-11
dailymed.nlm.nih.gov/dailymed/search.cfm?query=azacitidine

Stability of azacitidine in infusion fluids

The stability of azacitidine in four infusion fluids was studied. Azacitidine was reconstituted and diluted to final concentrations of 0.2 mg/ml and ...
pubmed.ncbi.nlm.nih.gov/6204528/

PDF Reference ID 4205640

Azacitidine for Injection is a nucleoside metabolic inhibitor indicated for the treatment of patients with the following FAB myelodysplastic syndrome ...
www.accessdata.fda.gov/drugsatfda_docs/label/2018/208216s001lbl.pdf

PDF Draft Guidance on Azacitidine May 2021

azacitidine from the test and RS formulations. It is recommended that the developed in vitro drug release method to support bioequivalence be based on ...
www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_050794.pdf

PDF HIGHLIGHTS OF PRESCRIBING INFORMATION ...

2.6 Preparation of Azacitidine for Injection Azacitidine for Injection is a cytotoxic drug. Follow applicable special handling and disposal ...
www.accessdata.fda.gov/drugsatfda_docs/label/2018/208216s002lbl.pdf

Azacytidine Vidaza in the treatment of myelodysplastic ...

The modulating effect of Azacitidine (Aza C) on the cytogenetically tracked MDS clone impact survival [abstract] Blood. 2004; 104:1429. [Google ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC1936359/

5-Azacytidine and 5-aza-2-deoxycytidine as inhibitors of ...

5-Azacytidine was first synthesized almost 40 years ago. It was demonstrated to have a wide range of anti-metabolic activities when tested against ...
pubmed.ncbi.nlm.nih.gov/12154409/

PDF Azacitidine Drug Monograph - Veterans Affairs

Azacitidine Drug Monograph Introduction The purposes of this monograph are to (1) evaluate the available evidence of safety, tolerability, efficacy ...
www.pbm.va.gov/clinicalguidance/drugmonographs/Azacitidine.pdf

Azacitidine-associated Sweets syndrome

Azacitidine was the apparent cause of Sweet's syndrome in a patient with MDS and another with CMML. Both responded well to corticosteroid therapy ...
pubmed.ncbi.nlm.nih.gov/22555082/

PDF NH N HO N O OH OH - Food and Drug Administration

VIDAZA (azacitidine for injection) Rx only For subcutaneous and intravenous use only DESCRIPTION VIDAZA (azacitidine for injection) contains azaciti ...
www.accessdata.fda.gov/drugsatfda_docs/label/2007/050794s005lbl.pdf

PDF RoC Profile Azacitidine 14th RoC 2016

which azacitidine causes tumors in experimental animals would not also operate in humans. Properties Azacitidine is a pyrimidine analogue of cytidine ...
ntp.niehs.nih.gov/ntp/roc/content/profiles/azacitidine.pdf